SPONSOR
Dartmouth-Hitchcock Medical Center
Total Trials
9
Recruiting
9
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: Triple Negative Breast CancerResidual DiseaseMild Cognitive ImpairmentAnxiety DisordersDepression DisordersMetastatic Breast CancerBreast CancerSensorineural Hearing LossHearing LossEpilepsy
Dartmouth-Hitchcock Medical Center is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Triple Negative Breast Cancer, Residual Disease, Mild Cognitive Impairment, Anxiety Disorders.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Dartmouth-Hitchcock Medical Center
How many clinical trials has Dartmouth-Hitchcock Medical Center sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Dartmouth-Hitchcock Medical Center, of which 9 are actively recruiting participants. These trials cover conditions including Triple Negative Breast Cancer, Residual Disease, Mild Cognitive Impairment. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Dartmouth-Hitchcock Medical Center research focus on?
Dartmouth-Hitchcock Medical Center clinical trials span Triple Negative Breast Cancer, Residual Disease, Mild Cognitive Impairment, Anxiety Disorders, Depression Disorders, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Dartmouth-Hitchcock Medical Center clinical trial?
To participate in a Dartmouth-Hitchcock Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Dartmouth-Hitchcock Medical Center trials with current recruitment status updated daily.
Clinical Trials by Dartmouth-Hitchcock Medical Center
NCT06134375 Phase 1, Phase 2
Recruiting
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Triple Negative Breast Cancer
NCT06102486
Recruiting
MCI Speech in Noise
Mild Cognitive Impairment
NCT06898593
Recruiting
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Anxiety Disorders
NCT05716516 Phase 2
Recruiting
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
Metastatic Breast Cancer
NCT06258993
Recruiting
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
Breast Cancer
NCT05107466
Recruiting
Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
Sensorineural Hearing Loss
NCT05529264
Recruiting
Human Intracranial Electrophysiology
Epilepsy
NCT06001736
Recruiting
Utility of CC7 Transfer in Stroke Subtypes
Stroke, Ischemic
NCT06951919
Recruiting
HOBSCOTCH-MS-Efficacy Trial
Multiple Sclerosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology